Trademark applications and grants for Vicuron Pharmaceuticals Inc. Vicuron Pharmaceuticals Inc has 37 trademark applications. The latest application filed is for "ZEVEN"
Patent Application | Date |
---|---|
DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL 20170190744 - 14/813914 STOGNIEW; MARTIN | 2017-07-06 |
ANTIBIOTICS GE 81112 FACTORS A, B, B1, PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS, AND USE THEREOF 20110286996 - 13/198754 Selva; Enrico ;   et al. | 2011-11-24 |
N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY 20100022605 - 12/097307 Jain; Rakesh Kumar ;   et al. | 2010-01-28 |
DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS 20090305953 - 12/474438 Colombo; Luigi ;   et al. | 2009-12-10 |
DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS 20090298749 - 12/476785 Stogniew; Martin ;   et al. | 2009-12-03 |
SEC | 0001052547 | VICURON PHARMACEUTICALS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.